NCT00804739

Brief Summary

The purpose of this project is to test whether a new model of collaborative care depression treatment adapted to the needs and preferences of low-income, urban mothers with perinatal depression and to a pediatric clinic setting increases engagement in and adherence to perinatal depression treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 9, 2008

Completed
23 days until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

February 27, 2012

Status Verified

February 1, 2012

Enrollment Period

3 years

First QC Date

December 8, 2008

Last Update Submit

February 23, 2012

Conditions

Keywords

Major DepressionPostpartum DepressionPerinatal DepressionTreatment FeasibilityTreatment EngagementTreatment AdherencePostpartumInterpersonal PsychotherapyIPTSertralineZoloft

Outcome Measures

Primary Outcomes (2)

  • Treatment Engagement

    6 weeks

  • Treatment Adherence

    18 weeks

Secondary Outcomes (5)

  • Treatment Response

    12 weeks

  • Treatment Remission

    12 weeks

  • Maternal functional assessment

    12 weeks

  • Maternal healthcare utilization

    18 weeks

  • Infant healthcare utilization

    18 weeks

Study Arms (1)

MITT

EXPERIMENTAL

Mothers will be assigned to the Mother-Infant Treatment Team (MITT)and will receive either psychotherapy or sertraline or both as well as outreach.

Other: Mother-Infant Treatment Team

Interventions

This is a treatment team approach that allows for outreach. The clinical team will be a nurse practitioner of psychiatry and a social worker. The nurse practitioner will provide either interpersonal psychotherapy, sertraline or both as indicated.

MITT

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mothers of infants 12 months of age or younger who present to the Pediatric Practice at Golisano Children's Hospital
  • Women who are 18 years of age or older
  • Mothers who understand and speak English sufficiently to participate in therapy with an English speaking provider
  • Have a current score of \> 10 on the EPDS
  • Provide written informed consent
  • Meet criteria for unipolar major depressive disorder.

You may not qualify if:

  • Women who:
  • do not speak or understand English well enough to participate in the therapy with an English speaking provider
  • are under 18 years of age
  • children are not cared for at the Pediatric Practice at the Golisano Children's Hospital
  • are actively psychotic, suicidal or homicidal,
  • require treatment (including additional psychotropic medications) not provided by MITT,
  • in the judgment of the MITT psychiatric provider require a higher level of psychiatric care (i.e. partial hospitalization, hospitalization, intensive case management),
  • are in active counseling or psychotherapy,
  • are under the care of a psychiatric provider and/or are receiving active treatment for depression including light therapy, ECT, or antidepressants
  • are receiving psychotropic medications not allowed in this study,
  • previously participated in and/or were terminated from the study,
  • have a diagnosis of bipolar disorder, schizophrenia, other psychotic disorder or alcohol/substance use disorder, and/or
  • have a medical condition or are taking medications that are contraindicated for sertraline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Depression, PostpartumDepressive Disorder, MajorTreatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental DisordersHealth BehaviorBehavior

Study Officials

  • Linda H Chaudron, MD, MS

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Psychiatry

Study Record Dates

First Submitted

December 8, 2008

First Posted

December 9, 2008

Study Start

January 1, 2009

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

February 27, 2012

Record last verified: 2012-02

Locations